Bio-S
30109635.960.00% ( 0.00 )
Bio-S (301096)
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primaril...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 35.96
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 77.17
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Bio-S Analyst Rating
View MoreForecast & Rating
Jul 29, 2025Price forecast
¥83.81133.08%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Nov 3, 2025 at 06:59 PM
Bio-S: Subsidiary Saimo Pharmaceutical plans to win bids for 12 varieties in the 11th national drug procurement
- 36Kr · Nov 2, 2025 at 07:31 PM
The three major A-share indices opened lower collectively, with new stock N Danna soaring 447.95% on its first day of listing
- Zhitong · Oct 24, 2025 at 08:01 AM
Bio-S released its performance for the first three quarters, with a net profit attributable to the parent company of 6.1242 million yuan, a decrease of 95.68%
- Zhitong · Sep 29, 2025 at 04:08 AM
Bio-S: Innovative drug BIOS-0623-Z4 tablets have received clinical trial approval
- Zhitong · Sep 25, 2025 at 12:43 AM
Innovative drug concept stocks surged and then fell back, with Mengke Pharmaceutical dropping over 10%, BrightGene, Bio-S falling over 7%, and YKYY, Konruns, EASTON BIOPHARMACEUTICALS, Fushine among those with the largest declines
- Zhitong · Sep 24, 2025 at 08:45 PM
Understanding the Market | XTALPI rose nearly 7% in the morning session as the company signed a letter of intent for cooperation with Bio-S to jointly promote AI new drug research and development cooperation
